JADO Technologies GmbH

Tatzberg 47-51
01307 Dresden
Germany

Phone

jado-tech.com

Contact

About JADO Technologies

Development of novel cell membrane acitve pharmaceuticals and strategies for intervention in lipid Rafts.

Product portfolio of JADO Technologies

Product portfolio

Show all

News about JADO Technologies

04-Jul-2008 | research and development

Jado initiates phase II trails of lead RAFT modulator in urticaria

JADO Technologies GmbH, a developer of RAFT intervention therapeutics, announced the start of a Phase II study to evaluate the safety and efficacy of oral ...

Read news

21-Feb-2008 | research and development

JADO reports clinical proof of concept with RAFT modulator in atopic dermatitis

JADO Technologies GmbH, developer of RAFT intervention therapeutics, announced positive results from a Phase IIa clinical trial of its lead RAFT modulator ...

Read news

01-Nov-2007 | business & finance

Jado Technologies licences clinical data from Æterna Zentaris for use of Miltefosine in allergy indications

Dresden based biotech JADO Technologies today signed an agreement with Aeterna Zentaris for access to clinical data for the marketed drug miltefosine. JADO ...

Read news

Show more news about JADO Technologies